Last reviewed · How we verify

E coli vaccine 1 Dose B (e-coli-vaccine-1-dose-b)

Pfizer Inc. · Phase 1 active Vaccine Quality 15/100

E coli vaccine 1 Dose B (generic name: e-coli-vaccine-1-dose-b) is a Vaccine drug developed by Pfizer Inc.. It is currently in Phase 1 development.

At a glance

Generic namee-coli-vaccine-1-dose-b
SponsorPfizer Inc.
ModalityVaccine
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about E coli vaccine 1 Dose B

What is E coli vaccine 1 Dose B?

E coli vaccine 1 Dose B (e-coli-vaccine-1-dose-b) is a Vaccine drug developed by Pfizer Inc..

Who makes E coli vaccine 1 Dose B?

E coli vaccine 1 Dose B is developed by Pfizer Inc. (see full Pfizer Inc. pipeline at /company/pfizer).

What is the generic name of E coli vaccine 1 Dose B?

e-coli-vaccine-1-dose-b is the generic (nonproprietary) name of E coli vaccine 1 Dose B.

What development phase is E coli vaccine 1 Dose B in?

E coli vaccine 1 Dose B is in Phase 1.

What are the side effects of E coli vaccine 1 Dose B?

Common side effects of E coli vaccine 1 Dose B include Anemia, Upper Respiratory Tract Infection, Systolic Hypertension, Tachycardia, Neutrophil Count Decreased, Hypoglycemia.

Related